Discover how next-generation lipid nanoparticles (LNPs) are revolutionizing Gene Editing by enabling safe, precise, and efficient delivery of CRISPR and RNA-based tools. Gene Editing is ready, and delivery is allowing translation Gene Editing has entered the golden era. Technologies like CRISPR-Cas9, base editors, and prime editors are [...]
Discover how lipid nanoparticles (LNPs) are powering a new era of personalized nanomedicine. Nanoparticle delivery systems are making bedside RNA therapies a reality. A paradigm shift: from mass production to personalized RNA therapies Imagine a future where life-saving RNA therapies are not manufactured [...]
The journey from scientific discovery to patient benefit is often long and uncertain. But in recent years, lipid nanoparticles (LNPs) have emerged as a key enabler for accelerating the clinical translation of innovative therapies, including mRNA, proteins, peptides, and gene-editing tools. At DIVERSA, we are designing next-generation nanoparticles that [...]
In recent years, the convergence of protein engineering and nanotechnology has emerged as a transformative force in biomedical science. These two fields, once developed along parallel lines, are now deeply intertwined, offering innovative solutions to some of medicine’s most complex challenges. From improving the stability and functionality of therapeutic [...]
Lipid nanoparticles (LNPs) have revolutionized the delivery of genetic therapies, most famously enabling the deployment of mRNA vaccines at a global scale. However, despite their remarkable success, conventional LNPs remain largely confined to a single target organ: the liver. For the field of nanomedicine to [...]
In recent years, lipid nanoparticles (LNPs) and additional types of nanoparticles (from liposomes to polymeric nanoparticles) have played a central role in the transformation of medicine, from enabling groundbreaking mRNA vaccines to delivering genetic therapies for rare diseases and cancer and decreasing toxicity of oncological [...]
Gene Editing has become one of the most promising areas in modern biotechnology, offering the potential to correct genetic mutations at their source. Tools like CRISPR/Cas9, base editors, and prime editing systems are opening new therapeutic frontiers in rare diseases, oncology, and regenerative medicine. However, the delivery of these gene editing [...]
While nanotechnology is widely recognized for its transformative role in medicine, its impact extends well beyond pharmaceuticals. The nutraceutical and cosmetic industries are increasingly turning to nanotechnology to enhance the efficacy, stability, and bioavailability of their products. From encapsulated vitamins to targeted skin delivery systems, the application of lipid nanoparticles and other nanocarriers, such as liposomes, [...]
The future of monoclonal antibody delivery with Lipid Nanoparticles Monoclonal antibodies (mAbs) have revolutionized modern medicine, offering targeted therapies for cancer, autoimmune diseases, and infectious diseases. However, their clinical potential is often hindered by challenges related to stability, bioavailability, and delivery efficiency. Traditional delivery [...]
Discover how nanoparticles are revolutionizing medical diagnostics, enabling early disease detection with greater precision and sensitivity. From oncology to neurological disorders, these innovations enhance imaging and personalize treatments. DIVERSA is driving the future of diagnostics with lipid nanoparticles for PET, SPECT, MRI, and fluorescence, advancing [...]
